Ionis Pharmaceuticals IONS
NASDAQ IONS
$58.09 -0.04 (-0.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Ionis Pharmaceuticals (IONS) Revenue Growth (5y) (2014 - 2026)

Analysis

Ionis Pharmaceuticals (IONS) Revenue Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ionis Pharmaceuticals 9.60 Bn 7.55 Bn 265.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.33%
Mar 31, 2026 17.13%
Dec 31, 2025 -6.87%
Sep 30, 2025 -0.42%
Jun 30, 2025 25.44%
Mar 31, 2025 -0.26%
Dec 31, 2024 -14.42%
Sep 30, 2024 -4.44%
Jun 30, 2024 6.58%
Mar 31, 2024 -16.66%
Dec 31, 2023 11.05%
Sep 30, 2023 -0.16%
Jun 30, 2023 9.86%
Mar 31, 2023 -2.00%
Dec 31, 2022 -1.97%
Sep 30, 2022 6.19%
Jun 30, 2022 3.57%
Mar 31, 2022 4.15%
Dec 31, 2021 22.37%
Sep 30, 2021 3.71%